ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novartis’ Cosentyx shows almost all psoriasis patients rapidly regain skin clearance following a tre
March 16, 2017Novartis announced a new analysis showing that moderate-to-severe psoriasis patients treated with Cosentyx (secukinumab) rapidly regain clear or almost clear skin (Psoriasis Area Severity Index, PASI 90 to 100) following relapse during a treatment pause.
Pharma Sources Insight January 2025
